Cited 7 times in
Insights on home blood pressure monitoring in Asia: Expert perspectives from 10 countries/regions
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 박성하 | - |
dc.date.accessioned | 2022-11-24T00:55:45Z | - |
dc.date.available | 2022-11-24T00:55:45Z | - |
dc.date.issued | 2021-01 | - |
dc.identifier.issn | 1524-6175 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/191087 | - |
dc.description.abstract | Hypertension is one of the most powerful modifiable risk factors for cardiovascular disease. It is usually asymptomatic and therefore essential to measure blood pressure regularly for the detection of hypertension. Home blood pressure monitoring (HBPM) is recognized as a valuable tool to monitor blood pressure and facilitate effective diagnosis of hypertension. It is useful to identify the masked or white-coat hypertension. There is also increasing evidence that supports the role of HBPM in guiding antihypertensive treatment, and improving treatment compliance and hypertension control. In addition, HBPM has also shown prognostic value in predicting cardiovascular events. Despite these benefits, the use of HBPM in many parts of Asia has been reported to be low. An expert panel comprising 12 leading experts from 10 Asian countries/regions convened to share their perspectives on the realities of HBPM. This article provides an expert summary of the current status of HBPM and the key factors hindering its use. It also describes HBPM-related initiatives in the respective countries/regions and presents strategies that could be implemented to better support the use of HBPM in the management of hypertension. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Wiley Periodicals Inc. | - |
dc.relation.isPartOf | JOURNAL OF CLINICAL HYPERTENSION | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Antihypertensive Agents / therapeutic use | - |
dc.subject.MESH | Asia / epidemiology | - |
dc.subject.MESH | Blood Pressure | - |
dc.subject.MESH | Blood Pressure Monitoring, Ambulatory* | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Hypertension* / diagnosis | - |
dc.subject.MESH | Hypertension* / drug therapy | - |
dc.subject.MESH | Hypertension* / epidemiology | - |
dc.title | Insights on home blood pressure monitoring in Asia: Expert perspectives from 10 countries/regions | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Ji-Guang Wang | - |
dc.contributor.googleauthor | Ma Lourdes Bunyi | - |
dc.contributor.googleauthor | Yook Chin Chia | - |
dc.contributor.googleauthor | Kazuomi Kario | - |
dc.contributor.googleauthor | Takayoshi Ohkubo | - |
dc.contributor.googleauthor | Sungha Park | - |
dc.contributor.googleauthor | Apichard Sukonthasarn | - |
dc.contributor.googleauthor | Jam Chin Tay | - |
dc.contributor.googleauthor | Yuda Turana | - |
dc.contributor.googleauthor | Narsingh Verma | - |
dc.contributor.googleauthor | Tzung-Dau Wang | - |
dc.contributor.googleauthor | Yutaka Imai | - |
dc.identifier.doi | 10.1111/jch.14074 | - |
dc.contributor.localId | A01512 | - |
dc.relation.journalcode | J01320 | - |
dc.identifier.eissn | 1751-7176 | - |
dc.identifier.pmid | 33043574 | - |
dc.identifier.url | https://onlinelibrary.wiley.com/doi/10.1111/jch.14074 | - |
dc.subject.keyword | Asia | - |
dc.subject.keyword | home blood pressure monitoring | - |
dc.subject.keyword | hypertension | - |
dc.contributor.alternativeName | Park, Sung Ha | - |
dc.contributor.affiliatedAuthor | 박성하 | - |
dc.citation.volume | 23 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 3 | - |
dc.citation.endPage | 11 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL HYPERTENSION, Vol.23(1) : 3-11, 2021-01 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.